We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+21.17%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$1.53B
AUM Growth
+$297M
(+24%)
Cap. Flow
+$65.9M
Cap. Flow
% of AUM
4.3%
Top 10 Holdings %
Top 10 Hldgs %
37.84%
Holding
2,861
New
260
Increased
962
Reduced
916
Closed
261
Avg Time Held Equity + Options
2.2
years
Top 10 Avg Time Held Equity + Options
1.5
years
Top 20 Avg Time Held Equity + Options
1.6
years
Avg Time Held Equity only
2.2
years
Top 10 Avg Time Held Equity only
1.5
years
Top 20 Avg Time Held Equity only
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$32M |
| 2 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$19M |
| 3 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$18.8M |
| 4 |
iShares US Medical Devices ETF
IHI
|
+$18.1M |
| 5 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$8.38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$30.2M |
| 2 |
iShares MSCI USA Size Factor ETF
SIZE
|
+$10.6M |
| 3 |
iShares US Treasury Bond ETF
GOVT
|
+$9.81M |
| 4 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$5.72M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$4.55M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 53.98% |
| 2 | Technology | 14.37% |
| 3 | Financials | 9.13% |
| 4 | Healthcare | 5.96% |
| 5 | Consumer Discretionary | 4.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
AbbVie
ABBV
$513B
| $2.4M | 0.16% |
24,472
+1,827
| +8% | +$161K |
2016 Q4
14 quarters
|
|
102
iShares MSCI Emerging Markets ETF
EEM
$29.3B
| $2.4M | 0.16% |
59,948
-10,784
| -15% | -$404K |
2016 Q4
14 quarters
|
|
103
Schwab US Broad Market ETF
SCHB
$44.5B
| $2.38M | 0.16% |
194,766
+9,156
| +5% | +$106K |
2016 Q4
14 quarters
|
|
104
PIMCO Enhanced Low Duration Active Exchange-Traded Fund
LDUR
$1.34B
| $2.37M | 0.15% |
23,260
-891
| -4% | -$89.3K |
2019 Q2
4 quarters
|
|
105
Bristol-Myers Squibb
BMY
$126B
| $2.36M | 0.15% |
40,206
+8,431
| +27% | +$504K |
2016 Q4
14 quarters
|
|
106
NextEra Energy
NEE
$165B
| $2.36M | 0.15% |
39,384
-4,104
| -9% | -$246K |
2016 Q4
14 quarters
|
|
107
Vanguard Morningstar Mega Cap ETF
MGC
$10.3B
| $2.35M | 0.15% |
21,452
-103
| -0.5% | -$10.7K |
2016 Q4
14 quarters
|
|
108
DraftKings
DKNG
$9.36B
| $2.34M | 0.15% |
70,468
+67,968
| +2,719% | +$1.88M |
2019 Q4
2 quarters
|
|
109
ServiceNow
NOW
$146B
| $2.2M | 0.14% |
27,215
+1,665
| +7% | +$118K |
2016 Q4
14 quarters
|
|
110
Vanguard Total World Stock ETF
VT
$81.4B
| $2.19M | 0.14% |
29,309
+6,390
| +28% | +$450K |
2016 Q4
14 quarters
|
|
111
Gilead Sciences
GILD
$198B
| $2.19M | 0.14% |
28,437
+363
| +1% | +$27.8K |
2016 Q4
14 quarters
|
|
112
CrowdStrike
CRWD
$247B
| $2.18M | 0.14% |
86,996
+84,368
| +3,210% | +$1.69M |
2019 Q3
3 quarters
|
|
113
Bank of America
BAC
$362B
| $2.16M | 0.14% |
90,972
+11,384
| +14% | +$269K |
2016 Q4
14 quarters
|
|
114
Pfizer
PFE
$170B
| $2.15M | 0.14% |
69,326
+10,180
| +17% | +$346K |
2016 Q4
14 quarters
|
|
115
Arcus Biosciences
RCUS
$2.9B
| $2.15M | 0.14% |
86,880
-734
| -0.8% | -$19.8K |
2019 Q2
4 quarters
|
|
116
Starbucks
SBUX
$110B
| $2.11M | 0.14% |
28,700
+493
| +2% | +$37K |
2016 Q4
14 quarters
|
|
117
Comcast
CMCSA
$76.7B
| $2.08M | 0.14% |
53,299
+9,313
| +21% | +$355K |
2016 Q4
14 quarters
|
|
118
Texas Instruments
TXN
$254B
| $2.06M | 0.13% |
16,219
-391
| -2% | -$45.6K |
2016 Q4
14 quarters
|
|
119
Vanguard Morningstar Growth ETF
VUG
$229B
| $2.03M | 0.13% |
60,318
-4,860
| -7% | -$149K |
2016 Q4
14 quarters
|
|
120
McDonald's
MCD
$173B
| $2.03M | 0.13% |
11,008
+410
| +4% | +$75.2K |
2016 Q4
14 quarters
|
|
121
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.2B
| $2.03M | 0.13% |
21,310
-1,378
| -6% | -$127K |
2016 Q4
14 quarters
|
|
122
Invesco S&P 500 Low Volatility ETF
SPLV
$7.24B
| $2M | 0.13% |
40,325
+8,847
| +28% | +$435K |
2018 Q3
7 quarters
|
|
123
Schwab US Large- Cap ETF
SCHX
$74B
| $1.99M | 0.13% |
161,532
-4,782
| -3% | -$55.7K |
2016 Q4
14 quarters
|
|
124
Honeywell
HON
$66.4B
| $1.96M | 0.13% |
14,379
-731
| -5% | -$96.7K |
2016 Q4
14 quarters
|
|
125
Accenture
ACN
$136B
| $1.95M | 0.13% |
9,064
-500
| -5% | -$94.6K |
2016 Q4
14 quarters
|
|
Similar funds
Parallel Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, Parallel Advisors held 2,861 positions worth $1.53B, up 24% from $1.24B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Parallel Advisors deployed $65.9M of net new capital in Q2 2020, opening 260 new positions and adding to 962 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 271,902 shares worth $19.7M.
By sector, the portfolio is most concentrated in Miscellaneous at 54% of assets, down from 54% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares MSCI USA Quality Factor ETF, an estimated $30.2M trimmed.
- Parallel Advisors's largest Q2 2020 buy was iShares MSCI USA Value Factor ETF: 271,902 shares worth $19.7M.
- Parallel Advisors added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2020, an estimated $32M increase.
- Parallel Advisors's biggest Q2 2020 reduction was iShares MSCI USA Quality Factor ETF, cutting an estimated $30.2M.
- Parallel Advisors fully exited iShares Core Dividend Growth ETF in Q2 2020, selling an estimated $3.38M.
- Parallel Advisors's ten largest holdings make up 38% of its $1.53B portfolio in Q2 2020.
- Parallel Advisors opened 260 new positions and closed 261 in Q2 2020.
- Parallel Advisors's portfolio value rose 24% quarter-over-quarter to $1.53B.
Based on Parallel Advisors's 13F filing for Q2 2020, filed 16 Jul 2020.